< Back to previous page

Patent

Functional cure of retroviral infection

The application relates to methods of curing retroviral infections, i.e. ensuring remission of retroviral infections, more particularly HIV infections, by administering a compound which is capable of binding to the LEDGF/p75 binding pocket of HIV-integrase and inhibiting LEDGF/p75-IN protein-protein interaction. The application further relates to the use of LEDGINs in retroviral gene therapy.
Patent Publication Number: US10806734
Source: USPTO
Year approval: 2020
Year publication: 2020
Status: Assigned
Validated for IOF-key: Yes